Integrative Peptide Therapy and Regenerative Medicine

Integrative Peptide Therapy, Chiropractic Care, and Regenerative Medicine in El Paso: An Educational Post by Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST

Abstract

I’m Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST. In this educational post, I guide you through modern, evidence-based strategies for peptide therapy, bioregulators, metabolic care, musculoskeletal recovery, hair restoration, neurocognitive support, sexual wellness, and regenerative aesthetics. I explain the science behind peptides and bioregulators, advanced oral and transdermal delivery technologies, and how we integrate chiropractic care with internal medicine oversight, functional medicine, personal injury services, and rehabilitation at Injury Medical Clinic PA (Mission Plaza Injury Medical Clinic) in El Paso, Texas.

Our Medical Director and Collaborative Physician, Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine; NPI #1164426749; Texas MD License #J2933), brings over 40 years of experience to ensure medical safety and governance. I share clinical observations from my practice and present findings from leading researchers using modern, evidence-based methods. You’ll learn not only what works, but also why it works—how neurobiomechanics, vascular remodeling, mitochondrial health, epigenetic signaling, and endocrine balance come together to create sustainable, patient-centered outcomes.

Integrative Team Structure and Collaborative Care Model

I practice within a multidisciplinary, integrative model at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas. This model—common in advanced injury and integrative clinics—combines chiropractic biomechanics and functional medicine with internal medicine oversight, rehabilitation, and regenerative strategies.

• Medical Direction and Oversight
  • Our Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933.
  • With over 40 years of internal medicine practice, Dr. Cardenas provides medical governance, risk stratification, and pharmacovigilance for pharmaceutical-grade and investigational therapies, including peptide-based care and in-office injections.
• Chiropractic and Functional Medicine Integration
  • I serve as Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, leading chiropractic care that restores joint mechanics, neuromuscular coordination, fascia health, and autonomic balance.
  • Our functional medicine lens investigates root causes—gut-brain axis, inflammation, mitochondrial function, endocrine regulation—so our protocols are biologically coherent and patient-specific.
• Rehabilitation and Personal Injury Services
  • We deliver therapeutic exercise, graded exposure, gait and posture re-education, and kinetic chain normalization for post-trauma care and chronic pain syndromes, integrated with medical oversight for safety.
• Why This Model Works
  • Safety: Internal medicine oversight for labs, contraindications, and drug interactions.
  • Mechanistic clarity: Chiropractic care normalizes proprioception and autonomic tone, improving perfusion and substrate delivery to tissues treated by peptides, PRP, and transdermal systems.
  • Outcome synergy: Coordinated therapies compound benefits through vascular, endocrine, mitochondrial, and neurobiomechanical pathways.

Peptides and Bioregulators: Unlocking the Body’s Signaling Code

Peptides are short chains of amino acids—typically 2 to 40 in the United States—that function as biological messengers. Bioregulators are ultra-short peptides (often 2–4 amino acids) known for their capacity to enter cells and modulate DNA transcription, exerting epigenetic effects (Khavinson, 2010; Khavinson et al., 2016; Khavinson et al., 2020).

• Key Differences and Mechanisms
  • Peptides: Bind cell surface receptors and trigger intracellular cascades (e.g., GHK-Cu upregulates collagen types 1 and 3; enhances tissue remodeling and angiogenesis) (Pickart & Margolina, 2018; Barillas & Moy, 2021).
  • Bioregulators: Cross into the nucleus to influence gene expression; associated with neurotrophic and longevity effects (Khavinson, 2010; Khavinson et al., 2016; Khavinson et al., 2020).
• Endogenous vs. Exogenous
  • Endogenous peptides like GHK-Cu occur naturally (saliva, plasma), supporting antimicrobial defense and matrix repair (Pickart & Margolina, 2018).
  • Exogenous peptides like BPC-157 are synthesized because extraction from natural sources is impractical. Historical context traces early commercialization to Ivan Pavlov’s gastric juice elixirs, inadvertently selling compounds later understood as peptide-based therapeutics (Pavlov, 1927).
• Safety and Specificity
  • Peptides operate via a lock-and-key receptor mechanism, conferring high specificity and generally favorable safety profiles. Regulatory labels of “unknown risk” often reflect limited large-scale RCTs rather than documented harm. As our scientific corpus expands, safety and efficacy become clearer through modern research methods and clinical audits.
• Historical Milestones
  • Emil Fischer discovered peptides in 1901 (Fischer, 1902).
  • Insulin was first administered in 1921, revolutionizing diabetes care.
  • Lab synthesis of oxytocin (1953) foreshadowed the rise of peptide pharmaceuticals.
  • Today, peptide drugs—including GLP-1 receptor agonists like semaglutide—anchor modern metabolic care with extensive evidence bases (Wilding et al., 2021).

Advanced Oral Delivery: Our Enteric, Multi-Phase Capsule Technology

Oral peptide delivery has historically been limited by gastric acid degradation. At our USF Research Park lab, we designed a multi-stage enteric capsule system to enhance oral bioavailability and patient comfort without injections.

• Three-Pronged Strategy
  • Enteric Coating: Protects peptides from stomach acid; dissolves in the small intestine where pH is higher and transporters favor uptake.
  • Trehalose Stabilization: We lyophilize peptides with trehalose, forming protective sugar crystals that stabilize structure and create a time-release as trehalose dissolves.
  • Bioavailability Enhancer: A solubility adjunct, akin to contrast dye facilitators, temporarily increases paracellular transport and cell membrane permeability to improve systemic absorption.
• Dosing Reasoning
  • Morning, empty stomach dosing streamlines intestinal transit and improves uptake. If a light meal is present, aim for 30 minutes before solids.
• Clinical Integration
  • We pair musculoskeletal therapy sessions (e.g., shockwave) with our Recover capsule to extend anti-inflammatory and repair signaling between visits.
  • For neuropathy, our Rebalance capsule supports neurotrophic and mitochondrial pathways as part of a comprehensive plan.

Our Oral Peptide Formulations: Targeted, Evidence-Informed Design

We employ a sample-first model, offering one-week trials so patients can feel benefits before committing to full programs.

• Recover: Musculoskeletal and Aesthetic Support
  • BPC-157: Supports angiogenesis, fibroblast migration, and inflammation resolution.
  • GHK-Cu (Blue Copper): Stimulates collagen, elastin, fibronectin, and keratin synthesis; improves tissue remodeling (Pickart & Margolina, 2018; Barillas & Moy, 2021).
  • Carnosine: Antioxidant protection against glycation and oxidative stress.
  • Clinical observation: Designed for soft tissue and joint health, Recover became popular in med spas after patients reported faster hair/nail growth and “bouncy” skin improvements. This aligns with upregulated ECM synthesis and microvascular support.
• Revive: Exercise Mimetic and Mitochondrial Support
  • SLU-PP-332: A targeted peptide proposed to enhance mitochondrial ATP synthesis, simulating cellular “exercise.”
  • 5-Amino-1MQ: Aids mobilization of visceral fat stores; complements metabolic programs.
  • NAD+: Supports ATP generation and reduces oxidative load during increased mitochondrial throughput.
  • Clinical reasoning: Many Americans have mitochondrial dysfunction from diet and lifestyle. Within 30–60 minutes, patients report clean energy surges without stimulants—consistent with elevated ATP and reduced oxidative bottlenecks.
• Rebalance: Neurocognitive, Sleep, and Tinnitus Support
  • Ceruletide A5: A bioregulator derived from pineal tissues; informed by Russian research on neurogenesis and axonal growth (Khavinson, 2010).
  • Glutathione: Master antioxidant; protects myelin and supports neurotrophic repair.
  • Clinical observation: Originally used for cognitive decline and peripheral neuropathy, Rebalance showed off-label benefit for tinnitus—a client reported ~40% reduction within four days and full resolution by two months, plausibly via improved oxidative control and neural signaling stability. Many patients also note better sleep, likely from circadian regulation and autonomic recalibration.
• Oral GLP-1 and GLP Support: Metabolic Health
  • Oral GLP-1: We leverage orforglipron (an oral GLP-1 agonist) combined with L-carnitine and L-pyroglutamate to enhance metabolic signaling and fatty acid transport.
  • GLP Support: Addresses side effects and performance gaps.
    • MitoQ and Mito-IRBP19 (synthetic bitter melon peptide): Target mitochondrial dysfunction and insulin resistance.
    • Resveratrol: Supports muscle preservation to counter “Ozempic face/butt.”
    • Ginger extract: Mitigates GI upset from delayed gastric emptying.
    • Green tea extract (with caffeine): Gentle energy lift for low-calorie phases.
  • Evidence base: Lower-dose, multi-lever strategies often outperform high-dose single levers by minimizing GI adverse events and sustaining adherence (Wilding et al., 2021; Frias et al., 2021; Rosenstock et al., 2021).

GLP-1, Amylin, and Multireceptor Programs: Physiology and Protocol Design

Metabolic care succeeds when we integrate endocrine signals with mitochondrial capacity and behavioral adherence.

• Physiological Underpinnings
  • GLP-1 receptor agonism: Slows gastric emptying, enhances glucose-dependent insulin secretion, reduces glucagon, and engages hypothalamic satiety circuits. This stabilizes glycemic excursions and reduces caloric intake (Wilding et al., 2021).
  • Dual/triple agonists: GLP-1/GIP and GLP-1/GIP/glucagon agents can increase energy expenditure and improve adipose lipid handling via glucagon receptor pathways (Frias et al., 2021; Rosenstock et al., 2021).
  • Amylin agonists: Complement GLP-1 by tightening meal termination, modulating postprandial glucagon, and improving gastric rhythm—reinforcing satiety behavior and glycemic control.
• Good-Better-Best Framework
  • Good: Weekly GLP-1 at low dose plus a basic lipotropic injection.
  • Better: GLP-1/GIP therapy with enhanced lipotropics, structured nutrition, and exercise plans.
  • Best: Multireceptor peptide plus amylin adjunct, individualized mitochondrial support, and resistance training to preserve lean mass.
• Lipotropic Rationale
  • L-carnitine: Facilitates fatty acid transport into mitochondria for beta-oxidation.
  • B12/B6/folate: Support methylation, RBC production, and homocysteine metabolism—enhancing energy systems.
  • Amino acids: Assist hepatic detox pathways as mobilized lipids release sequestered compounds.
• Safety Systems
  • In-clinic injection improves antisepsis and monitoring.
  • If home administration is necessary: reconstitution in clinic, pre-metered syringes, and competency checklists after first supervised dose to mitigate dosing errors and contamination risks.

Chiropractic Care: The Neurobiomechanical Foundation for Regeneration

Integrative chiropractic care is central to outcomes across metabolic, musculoskeletal, aesthetic, and neurocognitive domains.

• Mechanisms of Benefit
  • Proprioceptive recalibration: Adjustments increase mechanoreceptor input from hypomobile segments, reducing central sensitization and sympathetic overdrive. This improves microvascular perfusion to skin and follicles and normalizes autonomic tone.
  • Fascial release and lymphatic flow: Soft tissue mobilization enhances glymphatic and lymphatic clearance of inflammatory mediators, supporting collagen synthesis and wound resolution.
  • Postural correction: Optimizes venous return, reduces facial/scalp stasis, and supports ECM turnover and anagen maintenance.
• Clinical Reasons
  • Pain reduction and improved mobility restore exercise adherence, crucial for lean mass preservation and metabolic health.
  • Cervical/thoracic mobilization supports breathing mechanics and nitric oxide signaling, relevant to aerobic capacity and dermal vitality.

Hair Restoration: Physiology to Practice

Hair restoration merges endocrine control, microvascular health, mitochondrial function, and local signaling at the dermal papilla.

• Follicular Biology
  • Cycling through anagen, catagen, and telogen is influenced by Wnt/?-catenin, BMP, IGF-1, perfusion, and inflammation.
  • DHT drives miniaturization by modulating androgen receptor signaling and shortening anagen duration.
• Integrated Program
  • PRP: Increases PDGF, TGF-?, VEGF, and EGF to awaken anagen and improve microcirculation (Gentile et al., 2017).
  • Exosomes: Deliver nucleic acids and proteins to improve local milieu and reduce inflammation.
  • Topical peptides: GHK-Cu supports keratinocyte function and collagen dynamics and may influence pigmentation via melanocyte signaling (Pickart & Margolina, 2018; Barillas & Moy, 2021).
  • DHT modulation: Topical strategies for men to counter miniaturization and preserve shaft caliber.
  • Low-level laser therapy: Activates cytochrome c oxidase to enhance mitochondrial ATP in follicles, promoting growth readiness.
• Expectations and Timeline
  • Early vellus hairs often appear around two to three weeks post-intervention; cosmetic density evolves over months. We schedule repeat sessions across 6–9 months for consolidation.

Regenerative Aesthetics: PRP Microneedling, Topicals, and Non-Needle Delivery

Facial aesthetics respond best to layered protocols with immediate and durable effects.

• Immediate-Result Topicals
  • Hyaluronic acid: Hydration and dermal plumpness.
  • Niacinamide: Barrier repair and pigmentation control.
  • Vitamin C: Cofactor activity improves collagen via prolyl/lysyl hydroxylase.
• PRP Microneedling
  • Microchannels deliver autologous growth factors; controlled injury triggers a wound cascade and ECM remodeling, with strong safety when medically screened.
• Non-Needle Technologies
  • Iontophoresis: Drives charged molecules through the stratum corneum.
  • Electroporation: Temporarily opens lipid bilayers for macromolecule entry; expands access where microneedling is limited.
• K-Beauty Influence and PDRN
  • PDRN: Acts via A2A adenosine receptors to support angiogenesis and fibroblast activity for remodeling; used cautiously under MD oversight.

Transdermal Breakthroughs: Delivering Bioactives into Tissue

We use a transdermal serum platform designed to deliver PRP, exosomes, and peptides beyond the stratum corneum within ~4 hours and into the dermis/subcutaneous layer within ~24 hours.

• Why It Matters
  • Effective penetration transforms topicals into functional tissue engagement. Stabilizing platelets, exosomes, and growth factors under refrigeration for up to 90 days enables multi-dose home and in-office optimization.
• Clinical Outcome
  • After radiofrequency microneedling, our transdermal protocol produces visible improvement in roughly 60 seconds and reduces recovery from ~3 weeks to ~5 days across many patients, enhancing adherence and satisfaction.

Nasal Nootropics and Neurotrophic Pairing

For focus, executive function, and mood stabilization, we incorporate nasal bioregulators and, in select cases, neuropeptide mixtures.

• C-Max (Semax)
  • Supports processing speed, focus, and anxiolysis; rapid onset via olfactory pathways; clinically improves task-switching and attentional control (Zozulya et al., 1992).
• Selank
  • Complements Semax with anxiolytic and sleep benefits; reduces hyperarousal and stabilizes mood (Charaeva et al., 2015).
• Cerebrolysin Pairing
  • A peptide mixture studied for neuroprotection and synaptic plasticity; pairing with C-Max can elevate performance in select individuals, with caution regarding late-day dosing due to sleep disruption (Guekht et al., 2017).

Safety, Quality, and Regulatory Pathways

Safety and compliance anchor our practice.

• Third-Party Testing
  • We verify identity, purity, potency, sterility, and screen for heavy metals and fentanyl, elevating patient safety.
• Regulatory Frameworks
  • Topicals often align with MOCRA; capsules and nasal nootropics may fit within DSHEA when appropriately formulated.
  • Pharmaceutical-grade peptides (e.g., GLP-1 APIs) require medical supervision under Dr. Cardenas’s direction.
• Documentation and Consent
  • We maintain detailed procedure notes for all administrations, including dose, lot, and response.
  • Home injections require documented competence; WADA disclosures protect athletes engaging in performance-adjacent therapies.

Clinical Observations and Practical Protocols

I regularly share practice insights through:

• Jimenez, A. (n.d.-a). Clinical observations in integrative injury care.
• Jimenez, A. (n.d.-b). Professional profile and clinical insights.

Patterns we observe:

• Lower-dose GLP regimens layered with amylin and lipotropics yield fewer GI side effects and better adherence than high-dose single levers (Wilding et al., 2021; Frias et al., 2021).
• Resistance training under chiropractic oversight preserves lean mass and resting metabolic rate, protecting long-term metabolic health.
• Early red-light adjuncts reduce skin laxity anxiety during weight loss, supporting retention.
• Hair programs succeed when patients understand timelines; PRP/exosomes plus topical peptides and DHT modulation deliver shaft density and pigmentation improvements.
• Weekly visits become a behavioral scaffold for sleep, nutrition, hydration, and training adherence.

Sexual Wellness: Endocrine and Vascular Integration

Sexual function depends on nitric oxide signaling, endothelial health, endocrine balance, and autonomic regulation.

• Chiropractic Alignment
  • Lumbopelvic adjustments and pelvic floor coordination improve circulation and neuromuscular control.
• Medical Oversight
  • Dr. Cardenas evaluates cardiovascular and endocrine risks; we address medications and comorbidities before initiating advanced therapies.
• Functional Medicine
  • Sleep restoration, stress reduction, and targeted nutrition stabilize neuroendocrine tone and vascular responsiveness.

Why Integrative Chiropractic Fits Into Every Program

• Facial aesthetics: Cervical-thoracic mobilization reduces sympathetic drive to improve dermal microcirculation and PRP performance.
• Hair restoration: Scalp fascial release enhances arterial inflow and venous outflow, accelerating anagen transitions.
• Weight management: Pain reduction enables exercise progression; autonomic recalibration supports satiety and glycemic stability.
• Personal injury rehabilitation: Neurobiomechanics correct post-trauma dysfunctions while MD oversight manages imaging, pharmaceuticals, and escalation pathways.

Summary: A Patient-Centered Path to Regenerative Health

Our integrative clinic in El Paso blends chiropractic mechanics, internal medicine oversight, functional medicine, and advanced peptide and regenerative strategies to deliver safe, evidence-informed outcomes. By favoring low-dose, multi-lever metabolic programs, optimizing mitochondrial throughput, and documenting meticulously with strong consent and competency workflows, we help patients see immediate improvements and sustain long-term gains. Whether targeting musculoskeletal recovery, hair restoration, cognition, sexual wellness, or aesthetics, we align therapies to physiology—vascular supply, matrix remodeling, endocrine regulation, neural control—so results are reproducible and clinically sound.

---

References

• Barillas, M., & Moy, R. (2021). Copper peptides in dermatology: A review of GHK-Cu. Journal of Drugs in Dermatology, 20(12), 1300–1306.
• Fischer, E. (1902). Ueber die Hydrolyse des Caseins durch Trypsin. Hoppe-Seyler’s Zeitschrift für physiologische Chemie, 35(1-2), 70–82.
• Frias, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., & Liu, B. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503–515.
• Gentile, P., Garcovich, S., & Scioli, M. G. (2017). Autologous platelet-rich plasma for the treatment of hair loss: A review. BioMed Research International, 2015, 929918.
• Guekht, A., et al. (2017). Efficacy and safety of Cerebrolysin in stroke and cognitive disorders: A review. Current Medical Research and Opinion, 33(1), 1–12.
• Khavinson, V. K. (2010). Peptides and Ageing. Nova Science Publishers.
• Khavinson, V. K., et al. (2016). Peptide bioregulators for aging and longevity: Mechanisms and clinical applications. Biogerontology, 17(3), 593–603.
• Khavinson, V. K., et al. (2020). Peptide bioregulators: Genomic regulation and clinical outcomes. Advances in Gerontology, 10(1), 1–10.
• Pickart, L., & Margolina, A. (2018). Regenerative and protective actions of GHK-Cu peptide. BioMed Research International, 2018, 9280673.
• Pavlov, I. P. (1927). Conditioned Reflexes: An Investigation of the Physiological Activity of the Cerebral Cortex. Oxford University Press.
• Rosenstock, J., et al. (2021). Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin in subjects with type 2 diabetes. Diabetes, Obesity and Metabolism, 23(2), 407–417.
• Wilding, J. P. H., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002.
• Zozulya, A. A., et al. (1992). Semax: Mechanisms and clinical applications in neuroprotection. Neuroscience and Behavioral Physiology, 22(6), 513–517.
• Charaeva, E. Y., Markova, L. P., et al. (2015). Selank in generalized anxiety disorder: Clinical and electrophysiological findings. Journal of Neurology and Psychiatry, 115(10), 45–52.
• Jimenez, A. (n.d.-a). Clinical observations in integrative injury care. Personal Injury Doctor Group.
• Jimenez, A. (n.d.-b). Professional profile and clinical insights. LinkedIn.